A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/06/2011	US20110245320 Nuclease resistant double-stranded ribonucleic acid
10/06/2011	US20110245319 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110245317 Use of organic compounds
10/06/2011	US20110245316 Prevention or delay of onset of oral mucositis
10/06/2011	US20110245315 Indolyl or indolinyl hydroxamate compounds
10/06/2011	US20110245314 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
10/06/2011	US20110245313 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
10/06/2011	US20110245312 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
10/06/2011	US20110245311 Histidine Derivatives
10/06/2011	US20110245310 Novel Compounds
10/06/2011	US20110245309 N-methylpurine dna glycosylase and polymerase beta as biomarkers for alkylator chemotherapy potentiation
10/06/2011	US20110245308 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
10/06/2011	US20110245307 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement
10/06/2011	US20110245305 Pharmaceutical compositions for poorly soluble drugs
10/06/2011	US20110245304 Ribonucleotide reductase inhibitors and methods of use
10/06/2011	US20110245303 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
10/06/2011	US20110245302 Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
10/06/2011	US20110245301 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
10/06/2011	US20110245300 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245299 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245298 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
10/06/2011	US20110245297 Use Quaternary Pyridinium Salts as Vasoprotective Agents
10/06/2011	US20110245296 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	US20110245295 Bioactive pre-tubulysins and use thereof
10/06/2011	US20110245294 Methods of improving quality of sleep
10/06/2011	US20110245293 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
10/06/2011	US20110245292 2-hydroxy-ethanesulfonate salt
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245290 Alternative Forms of the Phosphodiesterase-4 Inhibitor N-Cyclopropyl-1--4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxyamide
10/06/2011	US20110245289 Novel substituted imidazoquinolines
10/06/2011	US20110245288 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
10/06/2011	US20110245287 Hybrid Opioid Compounds and Compositions
10/06/2011	US20110245286 Treatment of inflammation using alpha 7 receptor-binding agonists
10/06/2011	US20110245285 Process for preparation of rosuvastatin acetonide calcium
10/06/2011	US20110245283 Methods for predicting the response to statins
10/06/2011	US20110245282 Compounds
10/06/2011	US20110245281 Dispersible bosentan tablet
10/06/2011	US20110245279 Predictive marker for egfr inhibitor treatment
10/06/2011	US20110245278 Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith
10/06/2011	US20110245277 Famciclovir for the Treatment of Recurrent Herpes Labialis Using a One-Day Treatment
10/06/2011	US20110245276 Photostabilized pharmaceutical compositions
10/06/2011	US20110245275 Treatment of organophosphate exposure with ocinaplon
10/06/2011	US20110245274 Isoxazolines derivatives and their use as pesticide
10/06/2011	US20110245273 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/06/2011	US20110245272 Pyrido[4,3-b]indoles and methods of use
10/06/2011	US20110245271 Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/06/2011	US20110245270 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/06/2011	US20110245269 Inhibitors of Advanced Glycation End Products
10/06/2011	US20110245268 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245266 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
10/06/2011	US20110245265 Cxcr4 antagonists for kidney injury
10/06/2011	US20110245264 Modulators of G Protein-Coupled Receptor 88
10/06/2011	US20110245263 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd
10/06/2011	US20110245262 Compounds for treating proliferative disorders
10/06/2011	US20110245261 Antiprolactinic veterinary composition for ruminants
10/06/2011	US20110245260 Analogs of dehydrophenylahistins and their therapeutic use
10/06/2011	US20110245259 5-Amino-2-(1-Hydroxy-Ethyl)-Tetrahydropyran Derivatives
10/06/2011	US20110245258 Novel antimicrobials
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245256 Use of a pkc inhibitor
10/06/2011	US20110245255 Purine compounds
10/06/2011	US20110245254 Heterocyclic compounds as inhibitors of beta-lactamases
10/06/2011	US20110245253 Method for treating a pulmonary hypertension condition
10/06/2011	US20110245252 Pyrrolotriazine kinase inhibitors
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245250 Potassium ion channel modulators & uses thereof
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245247 Novel small molecule potentiators of metabotropic glutamate receptors
10/06/2011	US20110245246 Quinazoline Derivatives Useful as Anti-Tumor Medicament
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245244 Phenoxy acetic acids as ppar delta activators
10/06/2011	US20110245243 Compounds and compositions as cathepsin s inhibitors
10/06/2011	US20110245241 HIV Integrase Inhibitors
10/06/2011	US20110245240 Cgrp receptor antagonists
10/06/2011	US20110245239 Organic compounds
10/06/2011	US20110245238 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof
10/06/2011	US20110245237 Aryl-cyclohexyl-tetraazabenzo[e]azulenes
10/06/2011	US20110245236 Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds
10/06/2011	US20110245235 Systems, Methods, and Devices for Rehabilitation of Auditory System Disorders Using Pharmaceutical Agents and Auditory Devices
10/06/2011	US20110245234 Crystalline forms of sodium 4--2-methoxybenzoate
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245232 Novel small molecule potentiators of metabotropic glutamate receptors i
10/06/2011	US20110245231 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245229 Dihydropyrazolopyrimidinone derivatives
10/06/2011	US20110245228 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245224 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245221 Aryl isoxazole compounds with antitumoural activities
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245217 Methods for diagnosing and treating asthma
10/06/2011	US20110245216 Use of dhea derivatives for enhancing physical performance
10/06/2011	US20110245215 Transdermal delivery systems for active agents
10/06/2011	US20110245214 Organic compounds

1 ... 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 ... 7860